<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13525">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02930850</url>
  </required_header>
  <id_info>
    <org_study_id>TORR0002</org_study_id>
    <nct_id>NCT02930850</nct_id>
  </id_info>
  <brief_title>Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation</brief_title>
  <official_title>Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masimo Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared
      to hemoglobin measurements obtained from a laboratory hematology analyzer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this clinical investigation is to report on the accuracy of the
      Rad-67 and DCI Mini sensor to measure SpHb as compared to hemoglobin measurements obtained
      from a manual HiCN analytical method and automated Beckman Coulter laboratory hematology
      analyzers.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Noninvasive hemoglobin measurement compared with standard blood test</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Anemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be healthy and non-healthy subjects older than 1 month of age. Subjects will
        be recruited in diversified demographics (age, gender, ethnicity, skin tone,
        comorbidities, etc.)

        Subjects may be recruited for the study from the physician's clinical practice, or by
        advertisement. Information to be disseminated to subjects and any advertisements will be
        approved by the IRB for the site.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: Greater than one month

          -  Weight: Greater than or equal to 3kg

          -  The subject or the subject's legally authorized representative has given written
             informed consent/assent to participate in the study

        Exclusion Criteria:

          -  Subjects with skin abnormalities at the planned application sites that may interfere
             with sensor application, per directions-for-use (DFU) or trans-illumination of the
             site, such as burns, scar tissue, nail polish, acrylic nails, infections,
             abnormalities, etc.

          -  Subjects deemed not suitable for the study at the discretion of the investigator

          -  Subjects unlikely to be able to refrain from excessive motion during data collection.
             Excessive motion includes postural changes, making hand gestures, involuntary
             muscular movements, etc.

          -  Decision-impaired adult and pediatric subjects who are unable to give consent and
             assent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Melody Fang, BS</last_name>
    <phone>(949) 297-7659</phone>
    <email>clinicalresearchdept@masimo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cristina Johnson, MS Pharm</last_name>
    <phone>(949) 297-7576</phone>
    <email>clinicalresearchdept@masimo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wai and Tran Offices</name>
      <address>
        <city>Burbank</city>
        <state>California</state>
        <zip>91506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>San San Wai, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wai and Tran Offices</name>
      <address>
        <city>Burbank</city>
        <state>California</state>
        <zip>91506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lawrence Tran, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Masimo Clinical Laboratory</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92618</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacy Lobato, BS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orange Coast Women's Medical Group</name>
      <address>
        <city>Lake Forest</city>
        <state>California</state>
        <zip>92653</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Winter, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Office of Mohammed T. Bailony</name>
      <address>
        <city>National City</city>
        <state>California</state>
        <zip>91950</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed T. Bailony, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Office of Marina Raikhel, MD</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90717</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marina Raikhel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metrolina Nephrology Associates</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peale Chuang, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 10, 2016</lastchanged_date>
  <firstreceived_date>October 10, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
